Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology

  • Ovidiu Chioncel
    Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’ Bucharest Romania
  • John Parissis
    Heart Failure Unit, Department of Cardiology Attikon University Hospital Athens Greece
  • Alexandre Mebazaa
    University of Paris Diderot, Hôpitaux Universitaires Saint Louis Lariboisière, APHP Paris France
  • Holger Thiele
    Department of Internal Medicine/Cardiology Heart Center Leipzig at University of Leipzig Leipzig Germany
  • Steffen Desch
    Department of Internal Medicine/Cardiology Heart Center Leipzig at University of Leipzig Leipzig Germany
  • Johann Bauersachs
    Department of Cardiology & Angiology, Hannover Medical School Hannover Germany
  • Veli‐Pekka Harjola
    Emergency Medicine University of Helsinki, Helsinki University Hospital Helsinki Finland
  • Elena‐Laura Antohi
    Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’ Bucharest Romania
  • Mattia Arrigo
    Department of Cardiology University Hospital Zurich Zurich Switzerland
  • Tuvia Ben Gal
    Department of Cardiology, Rabin Medical Center Petah Tiqwa Israel
  • Jelena Celutkiene
    Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Medical Faculty of Vilnius University Vilnius Lithuania
  • Sean P. Collins
    Department of Emergency Medicine Vanderbilt University School of Medicine Nashville TN USA
  • Daniel DeBacker
    Department of Intensive Care CHIREC Hospitals, Université Libre de Bruxelles Brussels Belgium
  • Vlad A. Iliescu
    Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’ Bucharest Romania
  • Ewa Jankowska
    Department of Heart Disease Wroclaw Medical University, University Hospital, Center for Heart Disease Wroclaw Poland
  • Tiny Jaarsma
    Department of Health, Medicine and Health Sciences Linköping University Linköping Sweden
  • Kalliopi Keramida
    National Kapodistrian University of Athens Medical School Athens Greece
  • Mitja Lainscak
    Division of Cardiology, General Hospital Murska Sobota Murska Sobota Slovenia
  • Lars H Lund
    Heart and Vascular Theme, Karolinska University Hospital Stockholm Sweden
  • Alexander R. Lyon
    Imperial College London National Heart & Lung Institute London UK
  • Josep Masip
    Consorci Sanitari Integral, University of Barcelona Barcelona Spain
  • Marco Metra
    Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University of Brescia Brescia Italy
  • Oscar Miro
    Emergency Department Hospital Clinic, Institut d'Investigació Biomèdica August Pi iSunyer (IDIBAPS) Barcelona Spain
  • Andrea Mortara
    Department of Cardiology Policlinico di Monza Monza Italy
  • Christian Mueller
    Department of Cardiology and Cardiovascular Research Institute Basel (CRIB) University Hospital Basel Basel Switzerland
  • Wilfried Mullens
    Department of Cardiology Ziekenhuis Oost Genk Belgium
  • Maria Nikolaou
    Heart Failure Unit, Department of Cardiology Attikon University Hospital Athens Greece
  • Massimo Piepoli
    Heart Failure Unit, Cardiology, Emergency Department Guglielmo da Saliceto Hospital, Piacenza, University of Parma; Institute of Life Sciences, Sant'Anna School of Advanced Studies Pisa Italy
  • Susana Price
    Royal Brompton Hospital & Harefield NHS Foundation Trust London UK
  • Giuseppe Rosano
    Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana Rome Italy
  • Antoine Vieillard‐Baron
    INSERM U‐1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), UVSQ Villejuif France
  • Jean M. Weinstein
    Cardiology Department Soroka University Medical Centre Beer Sheva Israel
  • Stefan D. Anker
    Department of Cardiology (CVK) Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin Berlin Germany
  • Gerasimos Filippatos
    University of Athens, Heart Failure Unit, Attikon University Hospital Athens Greece
  • Frank Ruschitzka
    Department of Cardiology University Hospital Zurich Zurich Switzerland
  • Andrew J.S. Coats
    Pharmacology, Centre of Clinical and Experimental Medicine IRCCS San Raffaele Pisana Rome Italy
  • Petar Seferovic
    Faculty of Medicine University of Belgrade Belgrade, Serbia;

Description

<jats:title>Abstract</jats:title><jats:p>Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high mortality, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large spectrum of CS presentations resulting from the interaction between an acute cardiac insult and a patient's underlying cardiac and overall medical condition. Phenotyping patients with CS may have clinical impact on management because classification would support initiation of appropriate therapies. CS management should consider appropriate organization of the health care services, and therapies must be given to the appropriately selected patients, in a timely manner, whilst avoiding iatrogenic harm. Although several consensus‐driven algorithms have been proposed, CS management remains challenging and substantial investments in research and development have not yielded proof of efficacy and safety for most of the therapies tested, and outcome in this condition remains poor. Future studies should consider the identification of the new pathophysiological targets, and high‐quality translational research should facilitate incorporation of more targeted interventions in clinical research protocols, aimed to improve individual patient outcomes. Designing outcome clinical trials in CS remains particularly challenging in this critical and very costly scenario in cardiology, but information from these trials is imperiously needed to better inform the guidelines and clinical practice. The goal of this review is to summarize the current knowledge concerning the definition, epidemiology, underlying causes, pathophysiology and management of CS based on important lessons from clinical trials and registries, with a focus on improving in‐hospital management.</jats:p>

Journal

Citations (2)*help

See more

Report a problem

Back to top